Skip to main content
. 2015 Oct 14;7(3):3614–3622. doi: 10.18632/oncotarget.6118

Table 4. Univariate and multivariate survival analyses by baseline characteristics and treatment options.

Univariate analysis Multivariate analysis
mOS (95% CI), months P value Hazard ratio (95% CI) P value
All patients 3.9(2.931-4.869)
Age <50 (n=50) 3.6(2.677-4.523) 0.45
≥50 (n=88) 4.1(2.445-5.755)
Gender male (n=117) 3.7(2.807-4.593) 0.04 1
female (n=21) 6.8(4.987-8.597) 0.765(0.438-1.335) 0.35
Etiologies HBV (n=116) 3.6(2.578-4.812) 0.46
HCV (n=7) 3.7(2.642-4.953)
alcohol(n=10) 4.0(2.982-4.893)
others(n=5) 4.0(2.886-4.965)
Type
of PVTT
branches of portal vein (n=71) 6(4.761-7.239) <0.001 0.887(0.573-1.372) 0.6
main portal vein (n=67) 3.2(2.901-3.499) 1
Cirrhosis absent (14) 4.5(3.391-5.456)
precent (124) 3.4(2.333-4.456) 0.16
Child–Pugh score A (n=107) 5.2(4.186-6.214) <0.001 0.534(0.333-0.857) <0.001
B7 (n=31) 2.4(2.931-4.869) 1
ECOG PST 0-1 (n=99) 5.9(4.526-7.223) <0.001 0.495(0.267-0.796) <0.001
2 (n=39) 3.1(2.923-3.479) 1
Tumor nodules single (n=65) 6.6(3.225-8.987) 1
multiple (n=73) 3.5(2.945-5.003) 0.04 1.202(0.903-1.406) 0.1
Tumor diameter ≤5cm (n=26) 5.5(0.003-10.997) <0.001 0.452(0.258-0.794) <0.001
5-10cm (n=58) 6.2(5.240-7.16) 0.586(0.373-0.920)
>10cm (n=54) 2.4(1.886-2.914) 1
Tumor distribution Monolobar (n=83) 5.6(4.265-6.935) <0.001 0.584(0.383-0.892) <0.001
Bilobar (n=55) 3(2.318-3.682) 1
AFP ≤400 ng/ml (n=49) 5.4(4.6-6.2) 0.09 0.672(0.429-1.051) 0.1
>400 ng/ml (n=89) 3.5(2.853-4.147) 1
Treatment option Palliative (n=74) 3.0(2.719-3.281) 0.003 1
GKR (n=64) 6.1(4.706-7.494) 0.538(0.356-0.814) <0.001

P < 0.05 was considered statistically significant. All statistical analyses were conducted using SPSS 17.0 (SPSS 17.0 for Windows, SPSS, Chicago, III). GKR: gamma knife radiosurgery; PVTT: portal vein tumor thrombosis; PV: portal vein; HBV: hepatitis B virus; HCV: hepatitis C virus; ECOG: Eastern Cooperative Oncology Group; INR: international normalized ratio; AFP: alpha fetal protein.